Click on a filter below to refine your search. Remove a filter to broaden your search.
The authors say that the review findings are limited by heterogenous definitions of long COVID in published studies.
Compared with placebo, normalization of C-reactive protein and oxygen saturation was faster, with improvements seen on day 3 of treatment.
SARS-CoV-2 vaccination appears to have no positive or negative impact on cognitive function or fatigue.
Individuals with breakthrough infection have an increased risk for death and postacute sequelae compared with contemporary controls.
Persisting evidence of cardio-renal involvement and hemostasis pathway activation was reported at 28 to 60 days after discharge.
Most SARS-CoV-2 infections are not asymptomatic; those with asymptomatic infections are less infectious.
No specific causes of symptoms of postacute sequelae of SARS-CoV-2 infection were identified.
Persistent viral shedding is associated with in-hospital delirium and increased six-month mortality.
Improvements were seen in physical and mental health, but survivors still have more symptoms than controls at two years.
No significant difference was seen in cycle threshold values based on variant, regardless of vaccination status.